Literature DB >> 9341745

Spleen cell survival and proliferation are differentially altered by docosahexaenoic acid.

J M Scherer1, W Stillwell, L J Jenski.   

Abstract

Omega-3 fatty acids have diverse health benefits that are not clearly understood. In this study we have examined the effects of the omega-3 fatty acid docosahexaenoic acid (DHA) on mitogen-activated and resting splenic lymphocytes. DHA inhibited lymphocyte proliferation, producing an apparent block or prolongation of S phase, without evidence for direct cytotoxicity. In contrast, DHA enhanced the survival of resting lymphocytes in culture without inducing cell cycling. When DHA was added at the start of culture, the survival advantage was apparent for 2 to 3 days, after which time typical lymphocyte attrition occurred. Using flow cytometry we observed that both T and B cell recoveries were increased by DHA, but there were DHA dose-dependent alterations of forward- and side-scatter characteristics, with some preference for B cells, perhaps indicating altered membrane properties. Our data imply that DHA may check ongoing immune response while concurrently preserving resting lymphocytes needed for subsequent immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341745     DOI: 10.1006/cimm.1997.1187

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

Review 1.  Effects of dietary n-3 polyunsaturated fatty acids on T-cell membrane composition and function.

Authors:  Kirsten C Switzer; David N McMurray; Robert S Chapkin
Journal:  Lipids       Date:  2004-12       Impact factor: 1.880

2.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid.

Authors:  Rafat A Siddiqui; Laura J Jenski; Kevin A Harvey; Jacqueline D Wiesehan; William Stillwell; Gary P Zaloga
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

3.  The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro.

Authors:  L J Jenski; J M Scherer; L D Caldwell; V A Ney; W Stillwell
Journal:  Lipids       Date:  1998-09       Impact factor: 1.880

4.  Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.

Authors:  Rafat A Siddiqui; Mustapha Zerouga; Min Wu; Alicia Castillo; Kevin Harvey; Gary P Zaloga; William Stillwell
Journal:  Breast Cancer Res       Date:  2005-06-07       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.